---
audienceLevel: patient
cancerTypes:
- general
citation: NCI, 2025
language: en
lastReviewed: '2025-12-30'
license: public_domain
reviewFrequency: quarterly
source: NCI
sourceType: 02_nci_core
status: active
tags:
- treatment
title: Vorasidenib Citrate - NCI
url: https://www.cancer.gov/about-cancer/treatment/drugs/vorasidenib-citrate
version: v1
---

# Vorasidenib Citrate - NCI

# Vorasidenib Citrate

Placeholder slot

(vor-uh-SIH-deh-nib SIH-trayt)

Vorasidenib citrate works by entering the brain and blocking the activity of abnormal IDH1 and IDH2 enzymes produced by IDH1 and IDH2 genes with certain mutations. By blocking these enzymes, vorasidenib citrate helps slow or stop the growth of certain types of brain tumors. It is a small-molecule drug (a drug that can enter cells easily).

US Brand Name(s)

Voranigo

FDA Approved

Yes

[FDA label information for this drug is available at DailyMed.](https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=31405fee-55b7-4857-987e-2724ee76be84&audience=consumer)

## Use in Cancer

Vorasidenib citrate
is approved to treat:

- **[astrocytoma](/Common/PopUps/popDefinition.aspx?id=45602&version=Patient&language=English)** or **[oligodendroglioma](/Common/PopUps/popDefinition.aspx?id=46257&version=Patient&language=English)** in adults and children aged 12 years and older that is [grade](/Common/PopUps/popDefinition.aspx?id=774694&version=Patient&language=English) 2, has an abnormal *[IDH1](/Common/PopUps/popDefinition.aspx?id=794150&version=Patient&language=English)* or *[IDH2](/Common/PopUps/popDefinition.aspx?id=790620&version=Patient&language=English)* gene, and has been treated with surgery, including biopsy, to partially or completely remove the tumor.

Vorasidenib citrate
is also being studied in the treatment of other types of
cancer.

## More About Vorasidenib Citrate

[Definition from the NCI Drug Dictionary](https://www.cancer.gov/publications/dictionaries/cancer-drug/def/774431) - Detailed scientific definition and other names for this drug.

## Research Results and Related Resources

[Engaging People with Low-Grade Glioma in Cancer Research](https://www.cancer.gov/news-events/cancer-currents-blog/2023/low-grade-glioma-optimum)

[Vorasidenib Treatment Shows Promise for Some Low-Grade Gliomas](https://www.cancer.gov/news-events/cancer-currents-blog/2023/vorasidenib-low-grade-glioma-idh-mutations)

[Targeted Therapy to Treat Cancer](https://www.cancer.gov/about-cancer/treatment/types/targeted-therapies)

## Clinical Trials Accepting Patients

[Find Clinical Trials for Vorasidenib Citrate](https://www.cancer.gov/research/participate/clinical-trials/intervention/C174942) - Check for trials from NCI's list of cancer clinical trials now accepting patients.
